This inventor holds 2 USPTO granted patents. Top assignees: Goethe-University Frankfurt, Helmholtz-Zentrum Fur Infektionsforschung Gmbh, University of California. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 28 
1 out of 16,025 
Years Active: 2023-2026
Title: The Innovations of Eugen Proschak
Introduction
Eugen Proschak is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmacology, particularly through his innovative work on dual inhibitors.
Latest Patents
Eugen Proschak holds a patent for "Orally available sEH/PDE4 dual inhibitors." This patent describes novel bioavailable dual inhibitors capable of inhibiting both soluble epoxide hydrolase (sEH) and phosphodiesterase 4 (PDE4), along with methods for their use. He has 1 patent to his name.
Career Highlights
Throughout his career, Proschak has worked with prestigious institutions, including the University of California and Goethe University Frankfurt. His research has focused on developing innovative therapeutic solutions that address complex health issues.
Collaborations
Eugen Proschak has collaborated with esteemed colleagues such as Bruce D. Hammock and Rene Bloecher. Their combined expertise has contributed to advancements in the field of drug development.
Conclusion
Eugen Proschak's work exemplifies the spirit of innovation in pharmacology. His contributions continue to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile